AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Dignify Therapeutics announced it raised $800,000 in an initial filing from an offering of $3 Million
PRIVATESep 25, 2026
Amount Raised
$800,000
Round Type
Seed
Research Triangle ParkBiotechnologyHealth Care
Company Information
Company
Dignify Therapeutics
Location
Research Triangle Park, North Carolina, United States
About
Dignify Therapeutics is a clinical-stage biopharmaceutical company focused on developing practical and convenient treatments for bladder and bowel voiding dysfunctions. Founded by a team of serial entrepreneurs and internationally recognized scientists, the company leverages a proven drug repositioning strategy honed over two decades in urology and gastroenterology. Backed by funding from founders, top venture capital firms like RA Capital Management and Eshelman Ventures, as well as public and governmental programs including the NIH SBIR/STTR initiative, Dignify has secured approximately $18 million in support. Based at the First Flight Venture Center in Research Triangle Park, North Carolina, Dignify is committed to advancing therapies that significantly improve patients' quality of life.
Fundz sees it the moment Dignify Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Research Triangle ParkBiotechnologyHealth Care